BVS FY 2022 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

FY 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$512M+18.8% YoY

Gross Profit

$331M64.6% margin

Operating Income

-$167M-32.7% margin

Net Income

-$159M-31.0% margin

EPS (Diluted)

$-2.59

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$15M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$960M

Stockholders' Equity

$325M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$512M	$431M	+18.8%
Gross Profit	$331M	$303M	+9.4%
Operating Income	-$167M	$12M	-1486.6%
Net Income	-$159M	$19M	-919.1%